Ligand · KT2
KT2 · 2-azanyl-9-[(1~{R},6~{R},8~{R},9~{R},10~{S},15~{R}, 17~{R},18~{R})-8-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)-3,9,12,18-tetrakis(oxidanyl)-3,12-bis(oxidanylidene)-2,4,7,11,13,16-hexaoxa-3$L^{5}, 12$L^{5}-diphosphatricyclo[13.2.1.0^{6,10}]octadecan-17-yl]-1~{H}-purin-6-one
KT2, 2-azanyl-9-[(1~{R},6~{R},8~{R},9~{R},10~{S},15~{R}, 17~{R},18~{R})-8-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)-3,9,12,18-tetrakis(oxidanyl)-3,12-bis(oxidanylidene)-2,4,7,11,13,16-hexaoxa-3$L^{5}…
- Component
- KT2
- Formula
- C21 H25 N9 O13 P2
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
KT2 in 1 structure; the first of them:
- 6S26 · Crystal structure of human wild type sting in complex with 2'-3'- cyclic-gmp-7-deaza-AMP · KT2 B401 · binds SER162, TYR163, GLY166, TYR167, ARG238, VAL239, TYR240, THR263 and 11 more
Residues it binds most
TYR 1, THR 1, ARG 1, GLY 1, PRO 1, SER 1, GLU 1, VAL 1 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.